The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
MRC SORCE trial: Analysis of patients' presenting characteristics, tumor staging, and surgical approach.
Alastair Ritchie
No relevant relationships to disclose
Alastair W. S. Ritchie
Disclosure not yet available
Angela M. Meade
Research Funding - Bayer
Louise Choo
No relevant relationships to disclose
Ben Smith
No relevant relationships to disclose
Andrew Welland
No relevant relationships to disclose
Adam Gregory
No relevant relationships to disclose
Richard S. Kaplan
Research Funding - Bayer
Tim Eisen
Consultant or Advisory Role - AVEO; Bayer; GlaxoSmithKline; Novartis; Pfizer; Roche
Honoraria - AVEO; Bayer; GlaxoSmithKline; Novartis; Pfizer; Roche
Research Funding - Bayer; Pfizer